Abbvie IncABBV
Price$283.40Intrinsic value$195.2031% below price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
21.5%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
29analysts covering
Analyst consensus, 29 analysts: PositiveAs of 18 Aug 2026
FY Revenue (est.)
$67.6Bnext fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
SKYRIZI Worldwide Net Revenues Quarterly4.5B
RINVOQ Worldwide Net Revenues Quarterly2.1B
Neuroscience Portfolio Net Revenues Quarterly2.9B
Watch Items
  • Humira Biosimilar Erosion Rate
  • Acquired In-Process R&D (IPR&D) Charges
Sign in / Sign up to read more

Research as of 2 Sep 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.